Kidney neoplasm
Therapeutic area
Nephrology
Rare disease
No
- Definition
- A benign or malignant neoplasm affecting the kidney. Representative examples of benign renal neoplasms include fibroma, lipoma, oncocytoma, and juxtaglomerular cell tumor. Representative examples of malignant renal neoplasms include renal cell carcinoma, renal pelvis carcinoma, Wilms tumor, rhabdoid tumor, sarcoma, and lymphoma.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Kidney neoplasm
- Therapeutic area
- Nephrology
- kidney neoplasm
- kidney neoplasm
- kidney neoplasm (disease)
- kidney tumor
- kidney tumour
- neoplasm of kidney
- neoplasm of the kidney
- renal neoplasm
- renal tumor
- renal tumors
- renal tumour
- renal tumours
- tumor of kidney
- tumor of the kidney
- tumour of kidney
- tumour of the kidney
- Severity
- Severe
- Nephrology
- Oncology
- MONDO ID
- MONDO:0021163
- Parent condition
- MONDO:0005240
Related records
Broader conditions (10)
- Cancer or benign tumor
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Human disease
- Kidney disorder
- Neoplasm
- Neoplastic disease or syndrome
- Urinary system disorder
- Urinary system neoplasm
Narrower conditions (104)
- Acquired cystic disease-associated renal cell carcinoma
- Adrenal cortex carcinoma
- Adrenocortical carcinoma, hereditary
- Adult kidney Wilms tumor
- Anaplastic sarcoma of the kidney
- Aniridia 2
- Aniridia 3
- Benign cystic nephroma
- Benign mesonephroma
- Benign metanephric tumor
- Benign neoplasm of renal pelvis
- Blastema predominant kidney Wilms tumor
- Carcinoma in situ of renal pelvis
- Cellular congenital mesoblastic nephroma
- Childhood kidney angiomyolipoma
- Childhood kidney cell carcinoma
- Childhood kidney neoplasm
- Childhood kidney Wilms tumor
- Childhood malignant kidney neoplasm
- Childhood multilocular cystic kidney neoplasm
Trials (985)
- (3D) Ultrasound Imaging Liver and Kidney
- [18]F-Fluciclatide for Kidney Cancer Imaging Studies and Treatment
- [18F]Fluciclatide PET Imaging of Pazopanib Response
- [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
- 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer
- 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors
- 177LuPSMA in Renal Cell Carcinoma
- 17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease
- 3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma
- 3D Virtual Models as an Adjunct to Preoperative Surgical Planning
- 6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney Cancer
- 64Cu-GRIP B in Patients With Advanced Malignancies
- 68Ga-PSMA PET in the Renal Cell Carcinoma
- 9-ING-41 in Patients With Advanced Cancers
- A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H...
- A CCafU-UroCCR Randomized Trial: 3D Image-Guided Robot-AssisTEd Partial Nephrectomy for Renal Complex Tumor (UroCCR N°99)
- A Clinical Study of the Living Renal Transplantation With Restored Kidneys Between Family Members
- A Clinical Study of the Living Renal Transplantation With Restored Kidneys Between Third Parties
- A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors
- A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer
Drugs in development (31)
- Acetaminophen Phase 2
- Aldesleukin Phase 3
- Axitinib Phase 3
- Bevacizumab Phase 3
- Capecitabine Phase 2
- Cyclophosphamide Phase 3
- Docetaxel Phase 3
- Everolimus Phase 3
- Fludarabine Phase 1
- Hydromorphone Phase 2
- Ibuprofen Phase 2
- Indisulam Phase 2
- Ipilimumab Phase 3
- Ketorolac Phase 2
- Mesna Phase 1
- Motexafin gadolinium Phase 2
- Mubritinib Phase 1
- Muromonab-CD3 Phase 2
- Nivolumab Phase 3
- Oxycodone Phase 2
Other linked drugs (1)
- Mannitol